From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 1m
Elevance Health Q3 2026 Earnings Preview
Wall Street expects Elevance Health to report a 22% earnings drop and 1.8% revenue contraction in Q3 2026.
In brief
Wall Street expects Elevance Health to report a 22% earnings drop and 1.8% revenue contraction in Q3 2026. Elevance Health faces 22% year-over-year earnings decline and 1.8% revenue contraction as Wall Street expects $4.69 EPS on October 21. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence…
Wall Street Expectations
Wall Street expects Elevance Health to report a 22% earnings decline and 1.8% revenue contraction in Q3 2026.
Consensus EPS Estimate
19 analysts expect $4.69 per share on revenue of $49.16 billion with EPS range $4.55 to $4.99.
Recent Estimate Revisions
EPS estimates edged up 0.6% from $4.66 but down 7.5% from $5.07 over the past 90 days.
Q3 2025 Performance
Elevance delivered $6.03 earnings per share on $50.1 billion revenue with 2.3% net margin.
Year-Over-Year Comparison
Consensus implies 22% earnings decline and 1.8% revenue contraction versus Q3 2025 results.
What to Watch
Focus on medical loss ratios, membership trends, and management commentary on cost management.
The one thing
Elevance Health faces 22% year-over-year earnings decline and 1.8% revenue contraction as Wall Street expects $4.69 EPS on October 21.
